IMDELLTRA
IMDELLTRA
Approved
DIN Number
02551578
Drug Class
Human
Market Date
Nov 28, 2024
Company
HC
Amgen Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02551578
AIG Number0166204002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L01FX33 TARLATAMAB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
TARLATAMABActive
Strength: 10 MG / VIAL
Monograph: TARLATAMAB